More Horsepower for Molecular Imaging
May 3, 2011 | Terry Sharrer
Last month, four of the UK’s leading research institutions-the Medical Research Council, Imperial College London, King’s College London, and University College London-formed a joint venture with GlaxoSmithKline to advance molecular imaging for translational medicine in neurology, oncology and cardiology. While this story has no details about the specific research agenda, it does hint at how the medical-industrial complex is working in Britain. MORE